{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:05:58Z","timestamp":1794571558559,"version":"4.9.1"},"reference-count":26,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["ZYLX201806"],"award-info":[{"award-number":["ZYLX201806"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["DFL20151601"],"award-info":[{"award-number":["DFL20151601"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600561"],"award-info":[{"award-number":["81600561"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Apheresis"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The artificial liver support system (ALSS) is used frequently as a first\u2010line treatment for hepatitis B virus\u2010associated acute\u2010on\u2010chronic liver failure (HBV\u2010ACLF). This study aims to compare the therapeutic efficacy of double plasma molecular adsorption system (DPMAS) with sequential half\u2010dose plasma exchange (PE) (DPMAS+PE) and full\u2010dose PE in patients with HBV\u2010ACLF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 131 hospitalized patients who were diagnosed with HBV\u2010ACLF and underwent DPMAS+PE or PE were retrospectively analyzed. According to the treatment methods used, they were divided into PE group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200977) and DPMAS+PE group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200954). The main evaluation indexes included the change of liver function and the 28\u2010days liver transplant\u2010free survival rates after the different treatments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were no significant differences on severity of illness between PE group and DPMAS+PE group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). The total bilirubin (TBIL) levels immediately after treatment, and at 24 and 72\u2009hours after treatment were markedly decreased in DPMAS+PE group than that in PE group (52.3\u2009\u00b1\u20099.4% vs 42.3\u2009\u00b1\u20097.2%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05; 24.2\u2009\u00b1 10.0% vs 13.5\u2009\u00b1\u200913.0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05; 24.8\u2009\u00b1\u200913.1% vs 14.9\u2009\u00b1\u200914.9%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05; respectively). The 28\u2010days survival rates was 62.3% and 72.2% in PE and DPMAS+PE groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.146). Furthermore, the 28\u2010days survival rates were significantly higher in DPMAS+PE group than that in PE group (57.4% vs 41.7%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.043) in the intermediate\u2010advanced stage patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compared with PE alone, DPMAS+PE might more effectively improve temporary TBIL in ACLF patients, and improve the 28\u2010days survival rates in HBV\u2010ACLF patients with intermediate\u2010advanced stage. Therefore, DPMAS+PE may be an available ALSS treatment for HBV\u2010ACLF patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jca.21690","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T13:57:14Z","timestamp":1550066234000},"page":"392-398","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Therapeutic effect of double plasma molecular adsorption system and sequential half\u2010dose plasma exchange in patients with HBV\u2010related acute\u2010on\u2010chronic liver failure"],"prefix":"10.1002","volume":"34","author":[{"given":"Jia","family":"Yao","sequence":"first","affiliation":[{"name":"Gastroenterology Department\uff0cGeneral Surgery Department Shanxi Dayi Hospital  Taiyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[{"name":"Difficult &amp; Complicated Liver Diseases and Artificial Liver Center Beijing Youan Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[{"name":"Difficult &amp; Complicated Liver Diseases and Artificial Liver Center Beijing Youan Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Luo","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School Lanzhou University  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yuan","sequence":"additional","affiliation":[{"name":"Gastroenterology Department\uff0cGeneral Surgery Department Shanxi Dayi Hospital  Taiyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Duan","sequence":"additional","affiliation":[{"name":"Difficult &amp; Complicated Liver Diseases and Artificial Liver Center Beijing Youan Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[{"name":"Gastroenterology Department\uff0cGeneral Surgery Department Shanxi Dayi Hospital  Taiyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Difficult &amp; Complicated Liver Diseases and Artificial Liver Center Beijing Youan Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-014-9580-2"},{"key":"e_1_2_6_3_1","article-title":"Development of diagnostic criteria and a prognostic score for hepatitis B virus\u2010related acute\u2010on\u2010chronic liver failure","volume":"67","author":"Wu T","year":"2017","journal-title":"Gut"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27406"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i48.7234"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002506"},{"key":"e_1_2_6_7_1","first-page":"345","article-title":"Liver support systems as perioperative care in liver transplantation\u2010historical perspective and recent progress in Japan","volume":"56","author":"Inoue K","year":"2010","journal-title":"Minerva Gastroenterol Dietol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(16)60084-X"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058738"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2006.00358.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2016.03.003"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.04.009"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12629"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20175"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21535"},{"key":"e_1_2_6_16_1","first-page":"177","article-title":"Diagnostic and treatment guidelines for liver failure (2012 version)","volume":"21","author":"Liver F","year":"2013","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.06.026"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.042"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation.V2012.1.7.3797920"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.08.018"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/039139880703001008"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-014-9534-8"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.5301\/ijao.5000341"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(14)60028-X"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.5847\/wjem.j.issn.1920-8642.2014.03.010"},{"key":"e_1_2_6_27_1","first-page":"1118","article-title":"Plasma exchange combining with plasma bilirubin adsorption effectively removes toxic substances and improves liver functions of hepatic failure patients","volume":"22","author":"Che XQ","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Journal of Clinical Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjca.21690","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jca.21690","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jca.21690","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jca.21690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T02:23:23Z","timestamp":1694312603000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.21690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1002\/jca.21690"],"URL":"https:\/\/doi.org\/10.1002\/jca.21690","archive":["Portico"],"relation":{},"ISSN":["0733-2459","1098-1101"],"issn-type":[{"value":"0733-2459","type":"print"},{"value":"1098-1101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"2018-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}